Index to Volume 3 of HIV Newsline

In the past year HIV Newsline has provided its readers -- 27,566 office-based clinicians and other healthcare providers -- with 174 pages of timely information on the latest advances in the treatment of patients with HIV infection, 14 pages more than the previous year. The dissemination of this information -- at no charge to recipients -- has been made possible by unrestricted educational grants from the sponsors listed below. Their continuing support in 1998 will enable us to continue to fulfill the editorial mission that Dr. Paul A. Volberding, Editor-in-Chief of HIV Newsline, set forth in our first issue: "To provide clinicians with pertinent, practical, up-to-the-minute information on the diagnosis and long-term management of one of the most complex disease entities ever confronted by healthcare providers."

Over the past year HIV Newsline has published articles, editorials, late-breaking news items, and brief commentaries on a wide range of subjects, from the management of pain in end-stage HIV disease to the diagnosis and treatment of multidrug-resistant TB. We devoted one entire issue to HIV disease in women and children, and another to the immediate future of antiretroviral therapy.

In response to overwhelming demand from our readers, their patients, and AIDS service organizations, we reprinted and distributed 7,500 copies of "Mastering Combination Therapy," a Pull Out and Save feature that appeared in the April issue of our sister publication, AIDS Care. At her specific request, we added President Clinton's new AIDS czar -- and all the members of the President's AIDS Advisory Council -- to our mailing list.

We will continue to provide readable, relevant, reliable information to our readers in the coming year -- to assist them in providing their patients with continuing care that is clinically sound, cost-effective, and compassionate.

The publication of HIV Newsline is supported by unrestricted educational grants from: Glaxo Wellcome Bristol-Myers Squibb Roche Laboratories Amgen Pfizer

The following index is arranged alphabetically by article title and by subject matter. Page numbers are provided for all entries except those that come from the unpaginated Pull Out and Save inserts that appear in every issue of HIV Newsline. The titles and subject matter of those inserts are listed by issue number.

Index: HIV Newsline, Volume 3

ALPHABETICAL LISTING | PULL-OUT INSERTS

SUBJECT LISTING:

Antiretrovirals

Opportunistic Infections and Other Conditions

Prevention / Transmission | Pediatrics

Case Studies | General

Alphabetical Listing	Page
ACTG 268: gradual vs. routine initiation of PCP prophylaxis	27
A good year, and the promise of a better one	131
A kiss is just a kiss	107
Antiretroviral therapy in children	96
Antiretroviral therapy in pregnant women	86
Approval sought for new formulation of saquinavir	64
At last, a protease inhibitor for children	18
Broad-based prevention programs have little impact on high-risk behavior	119
CDC reports substantial drop in AIDS deaths	36
Challenge of multidrug-resistant TB	108
Cidofovir for CMV retinitis	38
Cidofovir gel heals herpes lesions	137
Clinical significance of surrogate markers	57
Clinton administration proposes extending Medicaid to people with HIV	62
Combinations of reverse transcriptase inhibitors in children	92
Compliance: How you can help	67
Drug-drug interactions -- an update	140
Drug-resistant TB: Who is at risk?	115
Enthusiasm tempered by caution	51
Enhancing saquinavir levels with ritonavir	60
First genotypic test for HIV resistance	139
Gammaglobulin prevents infections	141
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB	116
Highlights of the 4th Conference	19
HIV/AIDS debate is over	3
HIV found in patients with "undetectable" viral levels	141
In treating MAC, less may be more	58
Isoniazid in HIV-positive patients at high risk for TB	113
Is resistance always a bad thing?	59
Joan J: A treatment-naïve patient who isn't naïve about treatment options	121
John L: A previously untreated patient with a CD4 count above 500	10
Low-dose AZT is effective in children	92
More on how HIV enters cells	137
Nevirapine in combination with protease inhibitors	16
New formulation of saquinavir	138
New macrolide inhibits late-stage HIV replication	63
Next generation of antiretroviral agents	73
Next generation of antiretroviral agents -- an update	143
Oral AZT may be equal to IV during delivery	95
Oral suspension of itraconazole effective against refractory candidiasis	14
Oxandralone for wasting syndrome	33
Paramomycin ineffective against cryptosporidiosis	34
Peter S: An extensively treated patient with rising viral load	29
Predictors of TB infection	113
Preventing vertical transmission: A wise investment	83
Problem of azole-resistant candidiasis	24
Problem of protease resistance	52
Protease inhibitor resistance and salvage therapy	132
Regression of PML in an aggressively treated patient	34
Risk factors and perinatal transmission	94
Skills-building prevention programs	118
Smoking increases risk of cryptococcosis	37
Study finds treatment of pain inadequate in AIDS patients	37
Transmission can be reduced among IVDUs	120
Pull-Out Inserts	Issue
Starting your patient on an antiretroviral regimen	I
Guide to management of severe pain in HIV-infected patients	II
Strategies to establish and maintain optimal adherence	III
U.S. Public Health Service recommendationsfor use of antiretroviral drugs during pregnancy	IV
Foods that can be eaten in conjunction with Crixivan	V
Optimal antiretroviral therapy for HIV infection	VI
Subject Listing	Page
(Listed in temporal order of publication)
Antiretrovirals
Nevirapine in combination with protease inhibitors	16
At last, a protease inhibitor for children	18
Highlights of the 4th Conference on Retroviruses	19
Management of pain in end-stage HIV disease	39
Enthusiasm tempered by caution	51
Problem of protease resistance	52
Is resistance always a bad thing?	59
Enhancing saquinavir levels with ritonavir	60
New macrolide inhibits late-stage HIV replication	63
Approval sought for new formulation of saquinavir	64
Compliance: How you can help	67
Next generation of antiretroviral agents	73
Antiretroviral therapy in pregnant women	86
Low-dose AZT is effective in children	92
Triple-drug therapy in infants	93
Oral AZT may be equal to IV during delivery	95
Antiretroviral therapy in children	96
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB	116
Protease inhibitor resistance and salvage therapy	132
New formulation of saquinavir	138
Next generation of antiretroviral agents -- an update	143
Opportunistic Infections and Other Conditions
Oral suspension of itraconazole effective against refractory candidiasis	14
Problem of azole-resistant candidiasis	24
ACTG 268: gradual vs. routine initiation of PCP prophylaxis	27
Oxandralone for wasting syndrome	33
Paramomycin ineffective against cryptosporidiosis	34
Regression of PML in an aggressively treated patient	34
Smoking increases risk of cryptococcosis	37
Cidofovir for CMV retinitis	38
In treating MAC, less may be more	58
Triple-drug therapy in infants	93
Challenge of multidrug-drug resistant TB	108
Isoniazid in HIV-positive patients at high risk for TB	113
Predictors of TB infection	113
Drug-resistant TB: Who is at risk?	115
Guidelines for administration of protease inhibitors and rifampin in HIV-positive patients with TB	116
Cidofovir gel heals herpes lesions	137
Gammaglobulin prevents infections	141
Prevention / Transmission
Preventing vertical transmission: A wise investment	83
Risk factors and perinatal transmission	94
A kiss is just a kiss	107
Skills-building prevention programs	118
Broad-based prevention programs have little impact on high-risk behavior	119
Transmission can be reduced among IVDUs	120
Pediatrics
At last, a protease inhibitor for children	18
Combinations of reverse transcriptase inhibitors in children	92
Low-dose AZT is effective in children	92
Triple-drug therapy in infants	93
Oral AZT may be equal to IV during delivery	95
Antiretroviral therapy in children	96
Case Studies
John L: A previously untreated patient with a CD4 count above 500	10
Peter S: An extensively treated patient with rising viral load	29
Joan J: A treatment-naïve patient who isn't naïve about treatment options	121
General
HIV/AIDS debate is over	3
CDC reports substantial drop in AIDS deaths	36
Study finds treatment of pain inadequate in AIDS patients	37
Management of pain in end-stage HIV disease	39
Clinical significance of surrogate markers	57
Clinton administration proposes extending Medicaid to people with HIV	62
First genotypic test for HIV resistance	139
HIV found in patients with "undetectable" viral levels	141
More on how HIV enters cells	137
Drug-drug interactions -- an update	140